SAGILITY RECENT GROWTH AND MARGINS IN FOCUS

is worth monitoring after reporting growth in its Q2 FY27 results. Net profit increased approximately 13% year-on-year to ₹284 crore, while revenue rose around 23% to ₹1,735 crore. The reported EBITDA margin remained near 25%. The company operates in healthcare-focused business process and technology services, where client demand, contract execution, employee costs and operating efficiency can affect performance. Key points to monitor: - Revenue growth and client additions - EBITDA margin sustainability - Operating costs and employee productivity - Business outlook and contract pipeline - Market response to the latest earnings My view: Revenue growth alongside a healthy reported margin provides useful indicators to examine. The next step is to assess whether the business can maintain profitability while expanding. Watch the price and volume confirmation before drawing a short-term trading conclusion. Disclosure: This note represents my independent research assessment. I do not hold this stock. This is for informational purposes and should not be considered a recommendation to buy or sell.